en es
Logo Junta
Logo Biobanco

R&D&I

Biomedical research requires biological samples and associated clinical data for its development. To respond to this, the SSPA Biobank hasn has a constant renewal and innovation of its procedures, developing its own R&D that has an impact on a higher quality of samples and on the improvement of procedures, directly contributing to an increase in the quality of biomedical research.

Currently, the SSPA Biobank has several lines of R&D in Biobanks:

  • Information systems for Biobanks and Donor Registry.
  • Strategies for sustainability, optimization and improvement of the operating procedures of the Biobank.
  • Pre-analytical variables of biological samples and search for quality markers.
  • Development and innovation in management and quality processes in biobanks.

These lines are the result of:

  • Research questions or needs identified in some of the areas of work of the SSPA Biobank: quality, communication, technological area and preservation.
  • The objectives committed to the Platformsmore Technological.
  • Collaborations with companies, research groups or working groups.
  • Development or validation of products/protocols/technologies.
  • Participation in clinical trials or research consortia.

R&D&I actions executed through the Recovery, Transformation andResilience.

The Research Area of the SSPA Biobank is involved in the development of the research project "Liquid biopsy solution for early cancer diagnosis through circulating RNA sequencing and machine learning methods," in collaboration with the LEITAT Technology Center and FLOMICS BIOTECH S.L. This is part of the action with reference CPP2021-008897, funded by MCIN/AEI/10.13039/501100011033 and by the European Union "NextGenerationEU"/PRTR. It is included in the grant resolution for public-private collaboration projects issued by the State Research Agency on December 23, 2022, under the State Program to Promote Scientific and Technical Research and its Transfer, from the State Plan for Scientific, Technical, and Innovation Research 2021-2023, within the framework of the Recovery, Transformation, and Resilience Plan.

R&D actions implemented in the 2021-2027 Operational Programme

In the Coordinating Node of the Biobank Research Area of the SSPA, R&D activities co-financed by both the European Regional Development Fund (ERDF) and the European Social Fund (ESF ) are carried out. Within the framework of pprogramming period 2021-2027, and in compliance with Annex XII of Regulation (EC) 1303/2013, which establishes the obligations in terms of Information and Communication on the support from these funds, the list of actions carried out is made public, which can be accessed through the following link, whose file contains essential information about them.

SSPA Biobank Scientific Publications

List of publications derived from the scientific activity of the SSPA Biobank

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015